NM_004463.3:c.395G>A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_004463.3(FGD1):​c.395G>A​(p.Arg132Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00196 in 1,209,766 control chromosomes in the GnomAD database, including 1 homozygotes. There are 720 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., 43 hem., cov: 23)
Exomes 𝑓: 0.0020 ( 1 hom. 677 hem. )

Consequence

FGD1
NM_004463.3 missense

Scores

1
2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 4.86

Publications

3 publications found
Variant links:
Genes affected
FGD1 (HGNC:3663): (FYVE, RhoGEF and PH domain containing 1) This gene encodes a protein that contains Dbl (DH) and pleckstrin (PH) homology domains and is similar to the Rho family of small GTP-binding proteins. The encoded protein specifically binds to the Rho family GTPase Cdc42Hs and can stimulate the GDP-GTP exchange of the isoprenylated form of Cdc42Hs. It also stimulates the mitogen activated protein kinase cascade leading to c-Jun kinase SAPK/JNK1 activation. Defects in this gene are the cause of the faciogenital dysplasia in Aarskog-Scott syndrome and a syndromatic form of X-linked cognitive disability. [provided by RefSeq, Jul 2017]
FGD1 Gene-Disease associations (from GenCC):
  • Aarskog-Scott syndrome, X-linked
    Inheritance: AD, XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0061568916).
BP6
Variant X-54471400-C-T is Benign according to our data. Variant chrX-54471400-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 95092.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 140 AD,XL gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGD1NM_004463.3 linkc.395G>A p.Arg132Gln missense_variant Exon 2 of 18 ENST00000375135.4 NP_004454.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGD1ENST00000375135.4 linkc.395G>A p.Arg132Gln missense_variant Exon 2 of 18 1 NM_004463.3 ENSP00000364277.3

Frequencies

GnomAD3 genomes
AF:
0.00124
AC:
140
AN:
112555
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000323
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000938
Gnomad ASJ
AF:
0.000753
Gnomad EAS
AF:
0.000280
Gnomad SAS
AF:
0.000365
Gnomad FIN
AF:
0.000483
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00206
Gnomad OTH
AF:
0.00198
GnomAD2 exomes
AF:
0.00132
AC:
242
AN:
183402
AF XY:
0.00124
show subpopulations
Gnomad AFR exome
AF:
0.000380
Gnomad AMR exome
AF:
0.000729
Gnomad ASJ exome
AF:
0.000935
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00100
Gnomad NFE exome
AF:
0.00227
Gnomad OTH exome
AF:
0.00177
GnomAD4 exome
AF:
0.00204
AC:
2236
AN:
1097161
Hom.:
1
Cov.:
31
AF XY:
0.00187
AC XY:
677
AN XY:
362863
show subpopulations
African (AFR)
AF:
0.000190
AC:
5
AN:
26368
American (AMR)
AF:
0.000909
AC:
32
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.000826
AC:
16
AN:
19380
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.000111
AC:
6
AN:
54106
European-Finnish (FIN)
AF:
0.00116
AC:
47
AN:
40529
Middle Eastern (MID)
AF:
0.00140
AC:
5
AN:
3576
European-Non Finnish (NFE)
AF:
0.00245
AC:
2065
AN:
841764
Other (OTH)
AF:
0.00130
AC:
60
AN:
46026
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
104
208
311
415
519
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00124
AC:
140
AN:
112605
Hom.:
0
Cov.:
23
AF XY:
0.00124
AC XY:
43
AN XY:
34769
show subpopulations
African (AFR)
AF:
0.000322
AC:
10
AN:
31031
American (AMR)
AF:
0.000937
AC:
10
AN:
10675
Ashkenazi Jewish (ASJ)
AF:
0.000753
AC:
2
AN:
2657
East Asian (EAS)
AF:
0.000281
AC:
1
AN:
3559
South Asian (SAS)
AF:
0.000366
AC:
1
AN:
2730
European-Finnish (FIN)
AF:
0.000483
AC:
3
AN:
6210
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.00206
AC:
110
AN:
53301
Other (OTH)
AF:
0.00195
AC:
3
AN:
1536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00188
Hom.:
84
Bravo
AF:
0.00122
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00381
AC:
11
ESP6500AA
AF:
0.000522
AC:
2
ESP6500EA
AF:
0.00312
AC:
21
ExAC
AF:
0.00135
AC:
164
EpiCase
AF:
0.00234
EpiControl
AF:
0.00249

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 14, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 05, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aarskog syndrome Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 11, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 29, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Sep 07, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

FGD1-related disorder Benign:1
Aug 07, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Intellectual disability Benign:1
Jul 27, 2020
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.49
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.10
T
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.85
D
M_CAP
Benign
0.044
D
MetaRNN
Benign
0.0062
T
MetaSVM
Benign
-0.61
T
MutationAssessor
Benign
0.34
N
PhyloP100
4.9
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.80
N
REVEL
Benign
0.091
Sift
Uncertain
0.011
D
Sift4G
Benign
0.26
T
Polyphen
0.50
P
Vest4
0.14
MVP
0.58
MPC
0.33
ClinPred
0.015
T
GERP RS
4.9
Varity_R
0.22
gMVP
0.080
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145644275; hg19: chrX-54497833; COSMIC: COSV64308265; API